Reemergence of Scabies Driven by Adolescents and Young Adults, Germany, 2009–2018

A necdotal evidence from clinicians in Germany suggests an increase in scabies; sales of scabicides by pharmacies in Germany have quadrupled during 2012-2017 (1,2).In addition, clinicians and scientists have raised concerns about resistance to standard treatment (3).In Germany, scabies is not reportable, and no recent national incidence estimates exist.Scabies is diagnosed clinically, but confi rmation through skin scrapings or dermatoscopy is not always performed in Germany (1).The national guideline recommends a single application of permethrin 5% cream for common scabies (4).Ivermectin, licensed in Germany in 2016, is recommended in cases of crusted scabies, immunosuppression, and contraindications for topical treatment (4).A second application is recommended after 7-15 days in outbreaks and patients with crusted scabies, immunosuppression, or persistent infestation.We investigated incidence of scabies in Germany for 2009-2018. The StudyWe analyzed claims data of outpatients insured by German statutory health insurance (SHI) funds, Reemergence of Scabies Driven by Adolescents and Young Adults, Germany, 2009-2018